The activity changes of the urea-cycle enzymes were monitored in cultured foetal hepatocytes after dexamethasone and insulin treatments. Addition of dexamethasone induced the development of carbamoyl-phosphate synthetase, argininosuccinate synthetase, argininosuccinase and arginase activites as soon as day 16.5 of gestation. When insulin was added together with dexamethasone, it markedly inhibited the steroid-induced increase in carbamoyl-phosphate synthetase, argininosuccinate synthetase and argininosuccinase activities.
The activity changes of the urea-cycle enzymes were monitored in cultured foetal hepatocytes after dexamethasone and insulin treatments. Addition of dexamethasone induced the development of carbamoyl-phosphate synthetase, argininosuccinate synthetase, argininosuccinase and arginase activites as soon as day 16.5 of gestation. When insulin was added together with dexamethasone, it markedly inhibited the steroid-induced increase in carbamoyl-phosphate synthetase, argininosuccinate synthetase and argininosuccinase activities.
It is well documented that general protein degradation and urea synthesis are stimulated by glucagon and inhibited by insulin (Miller, 1961; Exton & Park, 1972) . In particular, glucagon administration (McLean & Novello, 1965; Snodgrass et al., 1978) , diabetes (Jorda et al., 1981) or starvation (Schimke, 1962) lead to an increase in urea-cycle enzyme activities in adult rat liver, although no effect of insulin has been found in vivo (McLean & Novello, 1965) or in vitro (Lin et al., 1982) .
Insulin and glucagon are secreted during the late-foetal period in the rat (Felix et al., 1969; Girard et al., 1971) , and it was shown that circulating insulin concentrations are high in the foetus and fall soon after birth. The five urea-cycle enzyme activities, namely CPS, OTC, ASS, ASL and arginase (EC 3.5.3.1) , are low during the foetal period and increase rapidly during the first day of life (Raiha & Suihkonen, 1968; Gautier et al., 1977) . These data suggested that the low enzyme activities during foetal life could result from the effect of the hormones secreted at this stage of development. Previous studies with whole foetalrat livers indicated that CPS, OTC, ASS and arginase could not develop without glucocorticoids, and ASL was the only enzyme of the cycle not affected by steroid addition or deprivation before term (Husson & Vaillant, 1979b turely by administration of glucagon (or dibutyryl cyclic AMP), and glucocorticoids had a synergistic effect on this action (Husson & Vaillant, 1982) .
In primary cultured foetal hepatocytes, the ASS, ASL and arginase activities were maintained at their initial values for a few days (Husson et al., 1983 (Husson et al., , 1984 . Dexamethasone and glucagon independently increased ASL and arginase activities and acted synergistically when added in combination to the culture medium (Husson et al., 1984) .
The present study was undertaken to determine the role of dexamethasone and insulin in the regulation of the five urea-cycle enzyme activities during foetal life.
Materials and methods Materials
Animals. Adult female rats (Wistar strain) were mated overnight and recognized as pregnant by a vaginal smear on the next morning. Parturition occurred at 21.5 days.
Chemicals. The materials used for cell isolation and culture were as reported previously (Husson et al., 1983 (Husson et al., 1984) . The cells were suspended in the culture growth medium containing 10% (v/v) charcoal-treated foetal-calf serum and cultured in 25 cm2 tissue-culture flasks at 37°C under 5% CO2 in air. After an attachment period of 4-5 h and every 24h thereafter, the medium was replaced by fresh medium with 5% foetal-calf serum and hormones. Cells were harvested and homogenized after 3 days of culture.
Assays ofurea-cycle enzyme activities. All enzyme assays were made on fresh extracts prepared as described previously (Husson et al., 1983) . Protein was measured by the method of Lowry et al. (1951) , with bovine serum albumin as standard. CPS and OTC activities were assayed by the method of Brown & Cohen (1959) . ASS and ASL activities were determined by the procedures of Ratner (1955) , and arginase was assayed as described by McLean & Gurney (1963) .
One unit of urea-cycle enzyme activity is defined as the production of 1 Mmol of product/h at 38°C. Results are expressed as means + S.E.M.. The numbers of observations being given in parentheses. Significance was determined by using a paired Student's t test.
Results and discussion
In previous studies, it was shown that foetal hepatocytes in culture constitute an ideal tool for studying the developmental regulatory mechanisms of ASS, ASL and arginase activities (Husson et al., 1983 (Husson et al., , 1984 . To specify this phenomenon further, we measured the five urea-cycle enzyme activities in hepatocytes cultured at different stages of maturation. From the available data, it has been shown that the younger the foetal cells are, the more actively they synthesize enzymes (Guguen-Guillouzo et al., 1980) . Effects of dexamethasone Cells from 15.5-19.5-day foetuses were cultured for 3 days with dexamethasone, and the requirements of the enzyme activities for the glucocorticoid inducer are compared in Table 1 . At every stage studied, CPS activity rose after dexamethasone addition. These results are in agreement with previous studies in vivo, where cortisol administration on 16.5-day foetuses produced a 2-fold increase in activity 24h later (Gautier et al., 1977) .
OTC is the only enzyme of the cycle that was never changed by steroid addition to the culture medium. Previous studies had shown that this activity was greatly depressed in corticosteroiddeprived foetuses (Gautier et al., 1977) Regulation of urea-cycle enzymes in foetal hepatocytes specific activities of ASS and ASL in cultured foetal hepatocytes as early as day 15.5 and day 16.5 respectively was found to be different from this after administration of cortisol in utero (Husson & Vaillant, 1982) . Although ASS activity was greatly depressed in hypophysectomized foetuses, a lack of effect of cortisol on both enzyme activities from intact foetuses had been previously observed (Schwartz, 1972; Husson & Vaillant, 1979b) . These results suggest that a suppressive phenomenon might counteract in utero the stimulation of these enzyme activities induced by the corticosteroids (Raiha & Edkins, 1977) .
In 15.5-day hepatocytes no basal CPS and ASL activities could be detected, but, when dexamethasone was added, the enzyme activities were at the same values as those of 16.5-day treated cells.
The inducing effect of dexamethasone on the specific activity of arginase in cultured foetal hepatocytes was found to be close to this after administration of cortisol in utero (Husson & Vaillant, 1979a) . The intensity of the response of the enzyme activity to the inducer was directly related to the stage of the cells used for the treatment. In 15.5-day cells, the activity was 12-fold higher in treated cells than in the paired controls, although the glucocorticoid-receptor activity has been shown to be very low at this stage . The inducibility decreased noticeably in older stages and, when 19.5-day hepatocytes were used, the activity was only 1.9 times higher in treated cells than in paired controls. In general, arginase was the most responsive when compared with the four other enzymes (Table 1) . This is the first report on the activity changes of the five urea-cycle enzymes in cultured foetal hepatocytes, and it can be seen that glucocorticosteroids act very differently on their development. Particularly, dexamethasone produces an increase in CPS, ASS, ASL and arginase activities at a precocious stage of liver organogenesis, even before the formation of functional adrenal glands.
The above results on urea-cycle enzymes during ontogenic development are quite different from those obtained in cultured adult hepatocytes, known to be less sensitive to dexamethasone alone (Gebhardt & Mecke, 1979; Lin et al., 1982) . The reason for this loss of sensitivity of cultured mature cells remains unclear, and the difference between foetal and mature hepatocytes in the mechanism of response to steroid stimulation requires investigation.
Action of insulin
During development, insulin stimulates or represses the activity of a number of enzymes, but little is known about its action on urea-cycle enzymes. Hepatocytes from 18.5-day foetuses were cultured for 3 days with insulin and with or without dexamethasone ( Table 2) .
Insulin when added alone had no significant effect on the enzyme activities, but, when incubated with dexamethasone, it produced a marked inhibitory effect on the steroid-induced increase of CPS, ASS and ASL activities. Particularly, the increase in ASS activity was completely abolished. These results are in agreement with the observations by Raiha & Edkins (1977) on ASS and ASL activities from foetal liver explants. OTC activity was not significantly changed by insulin addition. Arginase seems to be quite different from the others, since it was rather slightly increased after the hormone addition. However, the response of the enzyme activity was not synergistic when the two effectors were associated. Such an effect was also reported by McLean & Novello (1965) in adult-rat liver in vivo, and Grazi et al. (1972) have shown that insulin administration produced a large increase in arginase activity in chicken liver.
Several studies reported a similar antagonistic interaction of insulin and glucocorticoids, in Vol. 225 Reuber H35 cells (Wicks et al., 1974) and in foetal or adult hepatocytes (Ho et al., 1981; Nakamura et al., 1980) . By contrast, potentiation of insulin action by glucocorticoids has been also reported (Plas & Nunez, 1976; Amatruda et al., 1983) . The physiological meaning of these interactions remains unclear, and the mechanism by which insulin antagonizes or potentiates glucocorticoid action is not yet known. RNA synthesis has been shown to be implicated in the induction of urea-cycle enzyme activities by glucocorticoids (Schwartz, 1972; Husson et al., 1984) , and it is possible that insulin produces a transcriptional or post-transcriptional block (Andreone et al., 1982) . The present data confirm and extend previous indications suggesting that expression of some enzymes is repressed before birth (Raiha & Edkins, 1977; Ho et al., 1981) . Furthermore, they suggest that the high plasma insulin concentration may repress the development of CPS, ASS and ASL activities during foetal life. The fall in this concentration, and the plasma corticosterone release at birth (Corbier & Roffi, 1974) , could explain the rapid postnatal increase in these enzyme activities. 
